Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05312164

Physio-Anatomy Clinical Data Collection Study

This is an on-label clinical study design intended for the collection of three different types of interventional procedural data using FDA-cleared cardiac catheterization technologies and drugs, each used according to its product labeling and standard practice of medicine.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Veteran's Administration Palo Alto, Palo Alto, California, United States

Loading trial locations.

About this study

These devices and drugs are commonly used for patient evaluation during PCI procedures performed by Interventional Cardiologists. The three device technologies used in a single catheterization laboratory visit for assessment of the coronary arteries include:

  • A coronary angiography imaging system to X-ray the coronary arteries for the evaluation of vessel narrowing or blocking.
  • Pressure guidewire from one or more manufacturers for the measurement of coronary physiology parameters.
  • Gentuity® HF-OCT Imaging System with Vis-Rx® Micro-Imaging catheter for imaging and sizing of the stenosed coronary arteries.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients >18 years of age.
  • Patients provide written informed consent.
  • Clinical presentation consistent with suspected coronary disease.
  • Patients who are candidates for PCI and scheduled for coronary diagnostics in the cardiac catheter lab with the intent to perform a physiological assessment for de novo lesions with stenosis, if clinically indicated.

Exclusion criteria

  • Presence of acute ST Elevation Myocardial Infarction (STEMI) at the time of the cath lab procedure.
  • Contraindication for FFR examination or administration of vasodilators.
  • Bacteremia or sepsis.
  • Major coagulation system abnormalities.
  • Severe hemodynamic instability or shock.
  • Heart Failure NYHA Class IV.
  • Severe valvular heart disease.
  • Prior heart transplant.
  • Acute renal failure based on diagnostic practice of the treating physician at time of screening.
  • Patient is pregnant.
  • Patient is currently enrolled in another clinical study that may impact the results of this study.
  • Patient has other co-morbid condition(s) that, in the opinion of the Investigator, could limit their

Treatment and study plan

HF-OCT Imaging

Device

Subjects undergo HF-OCT imaging of stenosed coronary arteries

FFR Pressure Wire

Device

Subjects undergo FFR physiology assessment of stenosed coronary arteries

Angiography

Device

Subjects undergo angiography imaging of stenosed coronary arteries

Primary outcomes

  1. Collection of angiography images, HF-OCT images, and FFR pressure wire data

    Time frame: 2 years

    There are no efficacy or safety outcomes in this study. This study is a simple data collection study to help the sponsor develop next-generation HF-OCT software. Pressure wire data will be paired with HF-OCT images and angiography images for analysis to determine if the HF-OCT imaging technology can predict FFR physiology information from the OCT pullback.

Study contacts

Contact information is provided by the study sponsor or research team.

Arjun Bhat, MD, MBA

CONTACT

[email protected]

978-202-4108

Sponsors and collaborators

Lead sponsor

Gentuity, LLC

Industry

Registry information

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Apr 5, 2022
Registry last updated
Mar 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.